Triflusal
CAS No. 322-79-2
Triflusal( Triflusal, Disgren, Grendis, Aflen, Triflux )
Catalog No. M14050 CAS No. 322-79-2
Triflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 35 | In Stock |
|
| 10MG | 58 | In Stock |
|
| 25MG | 106 | In Stock |
|
| 50MG | 177 | In Stock |
|
| 100MG | 295 | In Stock |
|
| 200MG | 444 | In Stock |
|
| 500MG | 710 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTriflusal
-
NoteResearch use only, not for human use.
-
Brief DescriptionTriflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981.
-
DescriptionTriflusal is a platelet aggregation inhibitor that was discovered and developed in the Uriach Laboratories, and commercialised in Spain since 1981. Currently, it is available in 25 countries in Europe, Asia, Africa and America. It is a drug of the salicylate family but it is not a derivative of acetylsalicylic acid (ASA).
-
In Vitro——
-
In Vivo——
-
SynonymsTriflusal, Disgren, Grendis, Aflen, Triflux
-
PathwayAngiogenesis
-
TargetPDE
-
RecptorPDE| TXA2R
-
Research AreaInflammation/Immunology
-
Indication——
Chemical Information
-
CAS Number322-79-2
-
Formula Weight248.16
-
Molecular FormulaC10H7F3O4
-
Purity>98% (HPLC)
-
SolubilityEthanol: 50 mg/mL (201.48 mM); DMSO: 50 mg/mL (201.48 mM)
-
SMILESO=C(O)C1=CC=C(C(F)(F)F)C=C1OC(C)=O
-
Chemical Name2-acetyloxy-4-(trifluoromethyl)benzoic acid
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Acta Crystallographica Section A, 49 ( Pt 1), 10-22 (1993)
molnova catalog
related products
-
CI-1044
CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.
-
Homo Sildenafil
Homo Sildenafil is an analog of Sildenafil, It acts as a phosphodiesterase inhibitor.
-
Enoximone
Enoximone is a selective inhibitor of phosphodiesterase III (PDE3), with treatment of congestive heart failure.
Cart
sales@molnova.com